Trials / Completed
CompletedNCT06269796
Identification of Neuromotor Signs in Preschool Children Suspected of Developmental Coordination Disorder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 424 (actual)
- Sponsor
- University of Thessaly · Academic / Other
- Sex
- All
- Age
- 3 Years – 5 Years
- Healthy volunteers
- Accepted
Summary
This prospective study aimed to detect neuromotor signs early in preschool children suspected of Developmental Coordination Disorder (DCD). Preschool children aged 3-5 years old from municipal kindergartens in Thessaloniki participated in this study. The Little DCDQ questionnaire and the BOT-2 (Bruininks-Oseretsky Test of Motor Proficiency) were used for assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Little Developmental Coordination Disorder Questionnaire (LDCDQ) | The Little Developmental Coordination Disorder Questionnaire (LDCDQ) is a parent questionnaire consisting of 15 items designed to screen for motor coordination difficulties in 3- and 4-year-old children. It comprises 15 items grouped into two distinct factors: gross motor skills and fine motor skills. A Likert scale is used, ranging from one to five, where one (1) indicates "Not at all like your child" and five (5) indicates "Very much like your child". The total of the 15 items is added up to obtain a total score of 75. |
| DIAGNOSTIC_TEST | Bruininks- Oseretsky Test of Motor Proficiency 2nd Edition (BOT-2) | The BOT-2 is standardized for children and adolescents aged 4 to 21 years and 11 months, and the full test takes 45 to 60 minutes to perform. The BOT-2 test was used to detect deviation from the norm and the likelihood of a diagnosis for DCD. The BOT-2 measures fine and gross motor proficiency, with subtests focusing on stability, mobility, strength, coordination, and object manipulation. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-07-31
- Completion
- 2021-09-30
- First posted
- 2024-02-21
- Last updated
- 2024-04-03
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT06269796. Inclusion in this directory is not an endorsement.